"Analytical Tool – Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are three products already appreciated by many of our customers:

A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market

A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market

Hematological Cancers Drug Pipeline Update 2014*

The Package Includes:
- A progress analysis on current and emerging drugs
- Information on most companies active in R&D
- Information on key industry related projects
- Data from most important clinical trials
- Information on early developmental stage projects
- Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:
- Tracking cutting edge companies, therapies and new technologies
- Rapid identification of partners & competitors
- Laying down a comprehensive framework for further analysis of the field
- Producing presentations surrounding the development of hematological cancer therapeutics
- Identifying emerging products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of hematological cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Table Of Contents

Analytical Tool - Hematological Cancers

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • March 2015
  • by Global Data

Summary The Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, ...

Hematological Cancers Drug Pathway Analyzer 2015

Hematological Cancers Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 767 targeted molecular therapies known to affect more than 259 specific intracellular signaling pathways ...

Hematological Tumor - Pipeline Review, H1 2014

Hematological Tumor - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Global Markets Direct

Hematological Tumor - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hematological Tumor - Pipeline Review, H1 2014’, provides an overview of the Hematological Tumor’s therapeutic pipeline. ...


Download Unlimited Documents from Trusted Public Sources

Pathology Description

  • March 2015
    3 pages
  • Cancer  

  • United States  

    Europe  

    Japan  

View report >

Pathology Description in the US

  • January 2015
    154 pages
  • Mental Illness  

    Clinical Depres...  

    Cardiovascular ...  

  • United States  

View report >

Oncology Industry in Israel

  • January 2015
    69 pages
  • Oncology  

    Cancer  

  • Israel  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.